Insys Therapeutics, Inc.·4

Nov 21, 9:01 PM ET

Motahari Saeed 4

4 · Insys Therapeutics, Inc. · Filed Nov 21, 2017

Insider Transaction Report

Form 4
Period: 2017-11-17
Motahari Saeed
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (right to buy)

    2017-11-17+40,00040,000 total
    Exercise: $5.37Exp: 2027-11-16Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The option shall vest in 36 equal monthly installments until fully vested and exercisable on November 17, 2020.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_753562

    POA DOCUMENT